Our Take
The dose matters: two hours of lifting weekly hits the benefit plateau; more doesn't improve outcomes, and for cancer risk, less is better.
Why it matters
This is observational data, not proof of causation, but the sample size (nearly 150,000 people tracked 30 years) and specificity of the dose-response curve give practitioners a clear, achievable target that doesn't require gym membership or excessive time.
Do this week
Your primary care team: ask whether 90–120 minutes of resistance training per week fits your cardiovascular and neurological risk profile, especially if aerobic activity is already in your routine.
A three-decade cohort study confirms strength training's mortality benefit
Researchers analyzed data from three long-running U.S. health studies tracking nearly 150,000 nurses and other professionals over 30 years. Participants self-reported their strength training and aerobic activity every two years. Over that span, approximately 36,000 died, allowing researchers to correlate muscle-strengthening activity with early mortality risk (per the published study).
The key finding: people who performed 90 to 120 minutes of strength training weekly had a 13% lower risk of dying from any cause than those who did none. The benefit was strongest for cardiovascular disease (19% lower risk) and neurological conditions, primarily dementia (27% lower risk). The dose plateau was clear: beyond roughly two hours per week, additional strength training did not lower mortality further.
Combining one to two hours of weekly strength training with recommended aerobic activity (around 150 minutes weekly) produced the largest effect: a 45% reduction in all-cause mortality risk. One exception emerged: for cancer mortality, smaller amounts of strength training (under one hour per week) showed the protective association; higher volumes did not improve outcomes.
The mechanism bridges muscle metabolism and systemic health
Skeletal muscle, built through resistance training, is metabolically active tissue. After eating, muscle absorbs approximately 80% of blood glucose, either burning it for energy or storing it as glycogen, preventing dangerous blood-sugar swings and protecting against type 2 diabetes. This glucose disposal alone reduces a major driver of heart disease and early death.
Muscle also functions as an endocrine organ. When muscles contract, they release hormone-like messengers called myokines into the bloodstream. These suppress chronic, low-grade inflammation underlying heart disease, diabetes, and many cancers. They also signal the liver, fat tissue, blood vessels, bone, and brain to optimize fuel burning, blood flow, and tissue health. Grip strength, a proxy for whole-body strength, has been shown in international studies to predict early mortality more accurately than blood pressure.
Chronic resistance training also lowers blood pressure and maintains arterial elasticity, protecting against cardiovascular stiffening. The same vascular and metabolic improvements that shield the heart appear to lower dementia risk, though the link to brain health remains newer and less mechanistically certain.
The study was observational; it cannot prove causation. Participants who lift weights may be healthier in unmeasured ways. Self-reported training also cannot capture intensity or form. But researchers adjusted for diet, smoking, and aerobic activity, reducing confounding.
The dose is achievable without specialized equipment
Two short strength-training sessions per week targeting all major muscle groups, paired with daily aerobic activity, appears sufficient to lower mortality risk. No gym membership or heavy barbell is required. Bodyweight exercises, resistance bands, or light dumbbells suffice for the dose that showed benefit in this cohort.
The specificity of the 90–120 minute weekly window is practical: it avoids the "more is always better" trap and sidesteps the assumption that strength training requires significant time investment to matter. For practitioners integrating fitness into a busy schedule, this study offers a concrete, falsifiable target tied to measurable health outcomes across three decades of follow-up.